Lowkeyoptions
Nov 9, 2:46 PM
$IBRX OVERREACTION ON A DAY APPROVED FOR A WHOLE NEW COUNTRY
Nov 9, 2026 7:00 AM Eastern Standard Time
ImmunityBio and Rafa Announce Israeli Ministry of Health Approval of ANKTIVA® Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in Situ
$PFE $RGC $MRNA $SPCX
https://www.businesswire.com/news/home/20261109516206/en/
1 replies